Eva Schumacher-Wulf, Editor-in-Chief of Mamma Mia! Magazine, shared on LinkedIn:
“A little late, but certainly not too late, here are my highlights from this year’s SABCS 2025:
- Meeting dear friends, colleagues, physicians, scientists, and industry representatives in person – a real highlight!
- My participation in the panel discussion in the ABC Global Alliance session. It is always an honor to work with Fatima Cardoso and this amazing organization. The content was the Decade Report 2015-2025, Key achievements, Gaps and Inequities.
- New exciting data, for example, the lidERA Breast Cancer trial (oral SERD (giredestrant) in the adjuvant setting in patients with ER+, HER2-negative EBC) or HER2CLIMB-05 (tucatinib plus trastuzumab/pertuzumab as first-line maintenance therapy for HER2+ metastatic breast cancer after taxane-based induction) and several more.
- Important de-escalation studies for local breast cancer therapy, such as the Axsana/EUBREAST 3(R) study or the Insema study, both initiated in Germany.
- Overall, there were numerous contributions from Germany! This shows that we still play a global role as a cancer research nation. I say ‘still’ because we urgently need to reduce the bureaucratic hurdles in clinical trials if we want to continue to play an international role.
- Quality of life data from some studies with the finding that all side effects are manageable and tolerable and new therapies never have a negative impact on quality of life. That’s great news! However, after 8 lines of therapy for my metastatic breast cancer, I wonder what went wrong in my case, because that’s not quite how I experienced it. Or is it not me who is the problem, but the methods used to collect QoL data?
Immediately after my return, I had an eye surgery. The large amounts of steroids I had taken over the last few years had caused my lens to cloud over and my vision to drop to below 10 percent. This is a side effect that is rarely talked about, but it has now been repaired. So to everyone I passed at SABCS25: I probably just didn’t see you because I was half blind.”
More posts from SABCS 2025.
